NCT01515696View on ClinicalTrials.gov

Impact of Oral Application of Gastrografin on the Meconium Evacuation in Very Low Birth Weight Infants

PHASE4CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2010

Study Completion Date

February 28, 2011

Conditions
Meconium IleusVery Low Birth Weight Infant
Interventions
DRUG

Gastrografin

Patients will receive 3ml Gastrografin + 6ml sterile water/kg as a single dose via a nasogastric tube during the first 24 hours of life.

DRUG

Sterile water

Patients will receive 9ml/kg sterile water as a single dose via a nasogastric tube during the first 24 hours of life.

All Listed Sponsors
lead

Nadja Haiden,MD

OTHER

NCT01515696 - Impact of Oral Application of Gastrografin on the Meconium Evacuation in Very Low Birth Weight Infants | Biotech Hunter | Biotech Hunter